tm
Seeing Is Believing
tm
Seeing Is Believing
ARQT is currently covered by 6 analysts with an average potential upside of $18.37 (212.89%) from yesterday's end of day stock price of $1.84. Arcutis Biotherapeutics activity chart has currently 6 price targets and 21 ratings on display.
Analysts average stock forecasts to be materialized ratio is 8.33% with an average time for these price targets to be met of 6.25 days.
Highest price target for ARQT is $20, Lowest price target is $2, average price target is $11.
Most recent stock forecast was given by UY EAR from MIZUHO on 27-Oct-2023. First documented stock forecast 20-Mar-2020.
Currently, out of the existing stock ratings of ARQT - 15 which are a Buy (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
4
$2.16 (117.39%)
57
1 months 7 days ago
0/2 (0%)
$28.14 (1182.95%)
Buy
3 months 12 days ago
0/1 (0%)
$16.68 (50.06%)
Buy
22
$16.69 (314.31%)
24
3 months 24 days ago
0/7 (0%)
$16.75 (126.55%)
Buy
55
3 months 25 days ago
0/1 (0%)
$19.42 (54.58%)
Buy
7 months 22 days ago
0/1 (0%)
$19.5 (100.00%)
What is ARQT (Arcutis Biotherapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on ARQT (Arcutis Biotherapeutics) with a proven track record?
Which analyst has the current lower performing score on ARQT (Arcutis Biotherapeutics) with a proven track record?
Which analyst has the most public recommendations on ARQT (Arcutis Biotherapeutics)?
Which analyst is the currently most bullish on ARQT (Arcutis Biotherapeutics)?
Which analyst is the currently most reserved on ARQT (Arcutis Biotherapeutics)?
